These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 35116790)
1. Prognosis analysis of lobectomy and sublobar resection in patients ≥75 years old with pathological stage I invasive lung adenocarcinoma of ≤3 cm: a propensity score matching-based analysis. Chen C; Ni Q; Shi Y; Fu S; Pan X; Wang Y; Yang J; Wang R Transl Cancer Res; 2019 Apr; 8(2):574-582. PubMed ID: 35116790 [TBL] [Abstract][Full Text] [Related]
2. Sublobar resection versus lobectomy in patients aged ≤35 years with stage IA non-small cell lung cancer: a SEER database analysis. Gu C; Wang R; Pan X; Huang Q; Zhang Y; Yang J; Shi J J Cancer Res Clin Oncol; 2017 Nov; 143(11):2375-2382. PubMed ID: 28819775 [TBL] [Abstract][Full Text] [Related]
3. Sublobectomy for stage IA1-2 invasive lung adenocarcinoma with consolidation tumor ratio ≤ 0.25. Qi YF; Qiu ZB; Zhang C; Fu R; Yang XW; Chu XP; Chen ZH; Yang XN; Wu YL; Zhong WZ Thorac Cancer; 2022 Nov; 13(22):3174-3182. PubMed ID: 36208139 [TBL] [Abstract][Full Text] [Related]
4. Choice of the surgical approach for patients with stage I lung squamous cell carcinoma ≤3 cm. Chen C; Wang Y; Pan X; Fu S; Shi Y; Yang J; Wang R J Thorac Dis; 2018 Dec; 10(12):6771-6782. PubMed ID: 30746222 [TBL] [Abstract][Full Text] [Related]
5. Comparison of Lobectomy and Sublobar Resection for Stage IA Elderly NSCLC Patients (≥70 Years): A Population-Based Propensity Score Matching's Study. Zhang B; Liu R; Ren D; Li X; Wang Y; Huo H; Zhu S; Chen J; Song Z; Xu S Front Oncol; 2021; 11():610638. PubMed ID: 34026604 [TBL] [Abstract][Full Text] [Related]
6. Sublobectomy versus lobectomy for long-term survival outcomes of early-stage non-small cell lung cancer with a tumor size ≤2 cm accompanied by visceral pleural invasion: a SEER population-based study. Yu Y; Huang R; Wang P; Wang S; Ling X; Zhang P; Yu J; Wang J; Xiao J; Wang Z J Thorac Dis; 2020 Mar; 12(3):592-604. PubMed ID: 32274125 [TBL] [Abstract][Full Text] [Related]
7. Adjuvant treatment can improve prognosis in patients with non-small cell lung cancer ≤3 cm after sublobectomy: a propensity score analysis. Ma H; Cheng J; Yu Y; Liu B; Qin J; Xing W; Luo S J Thorac Dis; 2021 Jan; 13(1):312-321. PubMed ID: 33569211 [TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes of stage I NSCLC (≤3 cm) patients following segmentectomy are equivalent to lobectomy under analogous extent of lymph node removal: a PSM based analysis. Qu X; Wang K; Zhang T; Shen H; Dong W; Liu Q; Du J J Thorac Dis; 2017 Nov; 9(11):4561-4573. PubMed ID: 29268526 [TBL] [Abstract][Full Text] [Related]
9. Lobectomy Versus Sublobectomy in Metachronous Second Primary Lung Cancer: A Propensity Score Study. Yang X; Zhan C; Li M; Huang Y; Zhao M; Yang X; Lin Z; Shi Y; Jiang W; Wang Q Ann Thorac Surg; 2018 Sep; 106(3):880-887. PubMed ID: 29852145 [TBL] [Abstract][Full Text] [Related]
10. Non-lung cancer specific mortality after lobectomy or sublobectomy in patients with stage IA non-small cell lung cancer ≤2 cm: A propensity score analysis. Yin J; Zhao M; Lu T; Huang Y; Sui Q; Xi J; Lin Z; Xu S; Wang Q; Zhan C J Surg Oncol; 2019 Dec; 120(8):1486-1496. PubMed ID: 31602661 [TBL] [Abstract][Full Text] [Related]
11. Sublobar resection for lung adenocarcinoma less than 2 cm containing solid or micropapillary components radiologically presented as consolidation-to-tumor ratio (CTR) ≤0.25 [ground-glass opacity (GGO)]. Zhu M; Xu Y; Huang J; Yao Y; Tosi D; Koike T; Villamizar NR; Wang Z; Mao F; Luo Q; Tan Q Transl Lung Cancer Res; 2024 Jul; 13(7):1685-1694. PubMed ID: 39118896 [TBL] [Abstract][Full Text] [Related]
12. Oncologic outcomes of segmentectomy vs lobectomy in pathologic stage IA (≤2 cm) invasive lung adenocarcinoma: A population-based study. Li F; Zhao Y; Yuan L; Wang S; Mao Y J Surg Oncol; 2020 Jun; 121(7):1132-1139. PubMed ID: 32108349 [TBL] [Abstract][Full Text] [Related]
13. Sublobectomy versus lobectomy for stage I non-small cell lung cancer in the elderly. Qiu C; Wang G; Xu J; Cui L; Dong W; Ni Y; Qu X; Du J Int J Surg; 2017 Jan; 37():1-7. PubMed ID: 27890654 [TBL] [Abstract][Full Text] [Related]
14. A Matched Comparison Study of Uniportal Versus Triportal Thoracoscopic Lobectomy and Sublobectomy for Early-stage Nonsmall Cell Lung Cancer. Mu JW; Gao SG; Xue Q; Zhao J; Li N; Yang K; Su K; Yuan ZY; He J Chin Med J (Engl); 2015 Oct; 128(20):2731-5. PubMed ID: 26481738 [TBL] [Abstract][Full Text] [Related]
15. Comparison of prognostic impact of lymphovascular invasion in stage IA non-small cell lung cancer after lobectomy versus sublobar resection: A propensity score-matched analysis. Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI Lung Cancer; 2020 Aug; 146():105-111. PubMed ID: 32526600 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and computed tomography features associated with recurrence-free survival of patients with small-sized peripheral invasive lung adenocarcinoma after sublobectomy. Huo J; Luo T; Lv F; Li Q Quant Imaging Med Surg; 2023 Dec; 13(12):8144-8156. PubMed ID: 38106273 [TBL] [Abstract][Full Text] [Related]
17. The indication of completion lobectomy for lung adenocarcinoma ≤3 cm after wedge resection during surgical operation. Wang Y; Wang R; Zheng D; Han B; Zhang J; Zhao H; Luo J; Zheng J; Chen T; Huang Q; Sun Y; Chen H J Cancer Res Clin Oncol; 2017 Oct; 143(10):2095-2104. PubMed ID: 28616702 [TBL] [Abstract][Full Text] [Related]
18. Survival rates after lobectomy versus sublobar resection for early-stage right middle lobe non-small cell lung cancer. Lv X; Cao J; Dai X; Rusidanmu A Thorac Cancer; 2018 Aug; 9(8):1026-1031. PubMed ID: 29927089 [TBL] [Abstract][Full Text] [Related]
19. Sublobectomy versus lobectomy for stage IA (T1a) non-small-cell lung cancer: a meta-analysis study. Liu Y; Huang C; Liu H; Chen Y; Li S World J Surg Oncol; 2014 May; 12():138. PubMed ID: 24886396 [TBL] [Abstract][Full Text] [Related]
20. The prognostic influence of histological subtypes of micropapillary tumors on patients with lung adenocarcinoma ≤ 2 cm. Xu L; Zhou H; Wang G; Huang Z; Xiong R; Sun X; Wu M; Li T; Xie M Front Oncol; 2022; 12():954317. PubMed ID: 36033545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]